3 Further information

3.1 The Institute has produced cancer service guidance on colorectal cancer and technology appraisal guidance on imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours.

Sources of evidence

The evidence considered by the Interventional Procedures Advisory Committee is described in the overview.

Information for patients

NICE has produced information describing its guidance on this procedure for patients and their carers ('Understanding NICE guidance'). It explains the nature of the procedure and the decision made, and has been written with patient consent in mind.